Screening of innate immune receptors in neurodegenerative diseases: A similar pattern

Abreu, 2004, Innate immunity and toll-like receptors: clinical implications of basic science research, J. Pediatr., 144, 421, 10.1016/j.jpeds.2004.01.057 Akiyama, 2000, Inflammation and Alzheimer's disease, Neurobiol. Aging, 21, 383, 10.1016/S0197-4580(00)00124-X Asea, 2000, HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine, Nat. Med., 6, 435, 10.1038/74697 Asea, 2002, Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4, J. Biol. Chem., 277, 15028, 10.1074/jbc.M200497200 Beyreuther, 1991, Mechanisms of amyloid deposition in Alzheimer's disease, Ann. N.Y. Acad. Sci., 640, 129, 10.1111/j.1749-6632.1991.tb00204.x Bsibsi, 2002, Broad expression of Toll-like receptors in the human central nervous system, J. Neuropathol. Exp. Neurol., 61, 1013, 10.1093/jnen/61.11.1013 Chen, 2006, Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide, J. Biol. Chem., 281, 3651, 10.1074/jbc.M508125200 Chishti, 2001, Early onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695, J. Biol. Chem., 276, 21562, 10.1074/jbc.M100710200 Cluskey, 2001, Mechanisms of neurodegeneration in amyotrophic lateral sclerosis, Mol. Pathol., 54, 386 Dal Canto, 1994, Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis, Am. J. Pathol., 145, 1271 DiCarlo, 2001, Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice, Neurobiol. Aging, 22, 1007, 10.1016/S0197-4580(01)00292-5 Dudal, 2004, Inflammation occurs early during the Abeta deposition process in TgCRND8 mice, Neurobiol. Aging, 25, 861, 10.1016/j.neurobiolaging.2003.08.008 Dybdahl, 2002, Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4, Circulation, 105, 685, 10.1161/hc0602.103617 Eriksen, 2005, Molecular pathogenesis of Parkinson disease, Arch. Neurol., 62, 353, 10.1001/archneur.62.3.353 Fassbender, 2004, The LPS receptor (CD14) links innate immunity with Alzheimer's disease, FASEB J., 18, 203, 10.1096/fj.03-0364fje Franklin, 2005, The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system, Int. J. Hyperthermia, 21, 379, 10.1080/02656730500069955 Frasier, 2005, Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein, Exp. Neurol., 192, 274, 10.1016/j.expneurol.2004.07.016 Gurney, 1994, Transgenic-mouse model of amyotrophic lateral sclerosis, N. Engl. J. Med., 331, 1721, 10.1056/NEJM199412223312516 Gurney, 1994, Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation, Science, 264, 1772, 10.1126/science.8209258 Herber, 2004, Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice, Exp. Neurol., 190, 245, 10.1016/j.expneurol.2004.07.007 Iribarren, 2005, CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2, FASEB J., 19, 2032, 10.1096/fj.05-4578fje Kahle, 2000, Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain, J. Neurosci., 20, 6365, 10.1523/JNEUROSCI.20-17-06365.2000 Kahle, 2001, Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model, Am. J. Pathol., 159, 2215, 10.1016/S0002-9440(10)63072-6 Kakimura, 2002, Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins, FASEB J., 16, 601, 10.1096/fj.01-0530fje Kitazawa, 2005, Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease, J. Neurosci., 25, 8843, 10.1523/JNEUROSCI.2868-05.2005 Kramer, 2007, Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies, J. Neurosci., 27, 1405, 10.1523/JNEUROSCI.4564-06.2007 Lee, 2002, Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain, Neuromol. Med., 2, 29, 10.1385/NMM:2:1:29 Letiembre, 2007, Innate immune receptor expression in normal brain aging, Neuroscience, 146, 248, 10.1016/j.neuroscience.2007.01.004 Liu, 2005, LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide, Brain, 128, 1778, 10.1093/brain/awh531 Moore, 2005, Molecular pathophysiology of Parkinson's disease, Annu. Rev. Neurosci., 28, 57, 10.1146/annurev.neuro.28.061604.135718 Nguyen, 2004, Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis, J. Neurosci., 24, 1340, 10.1523/JNEUROSCI.4786-03.2004 Ozinsky, 2000, The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors, Proc. Natl. Acad. Sci. U.S.A., 97, 13766, 10.1073/pnas.250476497 Qureshi, 2003, Toll-like receptors and their role in experimental models of microbial infection, Genes Immun., 4, 87, 10.1038/sj.gene.6363937 Selkoe, 1991, The molecular pathology of Alzheimer's disease, Neuron, 6, 487, 10.1016/0896-6273(91)90052-2 Selkoe, 2001, Alzheimer's disease: genes, proteins, and therapy, Physiol. Rev., 81, 741, 10.1152/physrev.2001.81.2.741 Tahara, 2006, Role of toll-like receptor signalling in A{beta} uptake and clearance, Brain, 129, 3006, 10.1093/brain/awl249 Takeda, 2002, Recognition of lipopeptides by toll-like receptors, J. Endotoxin Res., 8, 459, 10.1179/096805102125001073 Teismann, 2004, Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation, Cell Tissue Res., 318, 149, 10.1007/s00441-004-0944-0 Town, 2005, The microglial “activation” continuum: from innate to adaptive responses, J. Neuroinflammation, 2, 24, 10.1186/1742-2094-2-24 Tsan, 2007, Pathogen-associated molecular pattern contamination as putative endogenous ligands of toll-like receptors, J. Endotoxin Res., 13, 6, 10.1177/0968051907078604 Underhill, 2003, Toll-like receptors: networking for success, Eur. J. Immunol., 33, 1767, 10.1002/eji.200324037 Vabulas, 2002, HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway, J. Biol. Chem., 277, 15107, 10.1074/jbc.M111204200 Vabulas, 2002, The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway, J. Biol. Chem., 277, 20847, 10.1074/jbc.M200425200 Vabulas, 2002, Heat shock proteins as ligands of toll-like receptors, Curr. Top. Microbiol. Immunol., 270, 169 Walter, 2006, The LPS receptor, CD14 in experimental autoimmune encephalomyelitis and multiple sclerosis, Cell Physiol. Biochem., 17, 167, 10.1159/000092078